Soleus Capital Management, L.P. Neogenomics Inc Transaction History

Soleus Capital Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$7.06 - $13.97 $3.25 Million - $6.43 Million	-460,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$12.15 - $35.28 $5.59 Million - $16.2 Million	460,000 New	460,000 $5.59 Million
Q4 2021 Feb 14, 2022	SELL	$30.49 - $48.49 $5.81 Million - $9.24 Million	-190,556 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$41.66 - $52.52 $6.73 Million - $8.48 Million	-161,451 Reduced 45.87%	190,556 $9.19 Million
Q2 2021 Aug 16, 2021	BUY	$36.62 - $51.69 $11.2 Million - $15.8 Million	306,056 Added 666.05%	352,007 $15.9 Million
Q4 2020 Feb 16, 2021	BUY	$36.08 - $56.47 $1.66 Million - $2.59 Million	45,951 New	45,951 $2.47 Million

293

125M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.8B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.